Study Protocol of the Korean EGFR Registry: A Multicenter Prospective and Retrospective Cohort Study in Nonsmall Cell Lung Cancer Patients With EGFR Mutation
The Clinical Respiratory Journal · 2025
DOI: 10.1111/crj.70043 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Clinical Respiratory Journal, 2025. Verfasst von Chang Dong Yeo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, Catholi…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, ErbB Receptors, Lung Neoplasms, Registries. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yuhan.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
The provision of treatment for epidermal growth factor receptor (EGFR)‐mutated nonsmall cell lung cancer (NSCLC) patients has increased in Korea. However, multicenter studies on the clinicopathologic dataset and treatment outcomes, using a large‐scale dataset, have not been conducted. The current study is a prospective and retrospective multicenter observational cohort study that registers all stages of EGFR‐mutated NSCLC patients.
Methods
The Korean EGFR Registry was designed to enroll 2000 patients with all stages of EGFR‐mutated NSCLC from 40 university hospitals across Korea. This study, encompassing both retrospective and prospective cohorts, aims to analyze clinical characteristics, treatment modalities, and outcomes in these patients. Data collection will include patient demographics, smoking history, quality of life assessments, pathological data, and treatment outcomes, with follow‐up until December 2026. The primary endpoint is disease‐free survival in patients who have undergone radical therapy (surgery and radiotherapy) or progression‐free survival in those receiving targeted therapy (first, second, and subsequent lines), chemotherapy (first and subsequent lines), combination therapy, and palliative/maintenance therapy according to stages of EGFR‐mutated NSCLC. The study will explore the diagnostic methods for EGFR mutations, clinical outcomes based on treatment modalities, and metastatic patterns in EGFR‐mutated NSCLC patients. Moreover, it will investigate various aspects, including the safety and efficacy of a new third‐generation EGFR tyrosine kinase inhibitor (TKI), lazertinib, approved for both first‐ and second‐line treatments.
Discussion
This study is expected to provide valuable insights into the epidemiology, risk factors, progression, and treatment outcomes of EGFR‐mutated NSCLC in Korea. The Korean EGFR Registry will contribute significantly to the understanding of the complex dynamics of EGFR‐mutated NSCLC, aiding in the development of more effective and personalized treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
- Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang Medical Center, Hanyang University College of Medicine, Seoul, Republic of Korea.
- Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.
- Division of Pulmonology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Division of Pulmonology, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
- Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea.
ORCID-Profile: Jeong Eun Lee, Seung Joon Kim
Förderung
- Yuhan
Zitieren
APA
Yeo, C. D., Park, D. W., Yoon, S. H., Kim, E. Y., Lee, J. E., Lee, S. Y., Choi, C. M., Oh, I. J., Kim, D. J., Ryu, J. S., Lee, J. C., Kim, Y. C., Jang, T. W., Lee, K. Y., Jang, S. H., Kim, S. J., & Korean EGFR Registry Investigators (2025). Study Protocol of the Korean EGFR Registry: A Multicenter Prospective and Retrospective Cohort Study in Nonsmall Cell Lung Cancer Patients With EGFR Mutation. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.70043
Vancouver
Yeo CD, Park DW, Yoon SH, Kim EY, Lee JE, Lee SY, et al. Study Protocol of the Korean EGFR Registry: A Multicenter Prospective and Retrospective Cohort Study in Nonsmall Cell Lung Cancer Patients With EGFR Mutation. The Clinical Respiratory Journal. 2025. doi:10.1111/crj.70043
BibTeX
@article{Yeo2025,
author = {Yeo, Chang Dong and Park, Dong Won and Yoon, Seong Hoon and Kim, Eun Young and Lee, Jeong Eun and Lee, Shin Yup and Choi, Chang-Min and Oh, In-Jae and Kim, Do Jin and Ryu, Jeong Seon and Lee, Jae Cheol and Kim, Young-Chul and Jang, Tae Won and Lee, Kye Young and Jang, Seung Hun and Kim, Seung Joon and Korean EGFR Registry Investigators, Korean EGFR Registry Investigators},
title = {Study Protocol of the Korean EGFR Registry: A Multicenter Prospective and Retrospective Cohort Study in Nonsmall Cell Lung Cancer Patients With EGFR Mutation},
journal = {The Clinical Respiratory Journal},
year = {2025},
doi = {10.1111/crj.70043}
}
EUVIMED